Interwoven Technologies
Request More Information

Transforming drug discovery: Novo Nordisk uses the power of AI and Azure with Microsoft Research

Developing high-quality medicine is a resource-intense endeavor that requires collaboration across Novo Nordisk.  Novo Nordisk aimed to scale a pipeline of drug discovery, development, and data science capabilities with AI and machine learning. In partnership with Microsoft Research, the teams built a Novo Nordisk AI platform on Azure AI and data stacks. Novo Nordisk amplified its culture of innovation by leveraging Microsoft Azure platform's AI capabilities across many use cases. The teams recently published initial results with predictive AI models for advanced risk detection in cardiovascular diseases, including an algorithm that can predict patients' cardiovascular risk better than the best clinical standards.  Read this case study for lessons learned.

View In New Tab

Transforming drug discovery: Novo Nordisk uses the power of AI and Azure with Microsoft Research published by Interwoven Technologies

Having our roots in the great northwoods of Upper Michigan and Northern Wisconsin, we've proudly served our clients for nearly 30 years and counting. We know and understand what it means to truly be a part of a community. We know that the people we work with are part of our circle of friends and family, and that each and every encounter builds on a relationship not only with those clients but with their friends and family. We want our customers to know that we value their business, and while they'll be treated with the respect a "small community" business offers they never receive "small" quality. We're highly trained professionals with years of experience in technology. Our clients are be able to keep business local, without having to sacrifice quality or pay a huge premium to do so. With highly competitive pricing and service, there's no reason to look elsewhere.